- Home
- NBP vs PRE Comparison
NBP vs PRE Comparison
Compare NBP & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NBP | PRE |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | Hong Kong |
| Employees | 32 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 379.3M | 369.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NBP | PRE |
|---|---|---|
| Price | $3.11 | $15.47 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 1 |
| Target Price | $9.00 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 432.4K | 299.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $110.85 |
| Revenue Next Year | N/A | $64.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.03 | $3.09 |
| 52 Week High | $5.19 | $22.86 |
Technical Indicators
Market Signals| Indicator | NBP | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 38.04 | 39.24 |
| Support Level | $3.04 | $12.71 |
| Resistance Level | $3.74 | $17.76 |
| Average True Range (ATR) | 0.20 | 1.72 |
| MACD | 0.01 | -0.54 |
| Stochastic Oscillator | 17.78 | 11.69 |
Price Performance
Historical ComparisonAbout NBP NovaBridge Biosciences American Depositary Shares
NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. It integrates scientific discovery with strategic planning and project management to move therapies from research toward potential patient use. Its pipeline includes Givastomig, VIS-101, Ragistomig and Uliledlimab.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.